- Home
- |
- About
- |
- Products
- |
- News and Media
- |
- Investors
- |
- Online Pharmacy
- |
- Contact Us
Medicure is a pharmaceutical company committed to the development and commercialization of innovative and affordable therapeutics for the U.S. market.
Our vision is to become a leading pharmaceutical company within the U.S., offering a growing portfolio of products that improve patients' lives.
We Bring Medicine to Life.
The product information provided below is intended for residents of the U.S. only. To report an adverse event or a product complaint, or to request information about our products, please visit our Drug Safety or Medical Information pages.
AGGRASTAT (tirofiban hydrochloride) for injectionFollowing approval of a new dosing regimen in 2013, AGGRASTAT is the most widely used glycoprotein inhibitor in the United States. See Aggrastat Patents. |
|
ZYPITAMAG (pitavastatin) tabletsZYPITAMAG is a statin (HMG-CoA reductase inhibitor) medication approved by the U.S. Food and Drug Administration (FDA) in July 2017. See Zypitamag Patents. |
Leadership
Board of Directors
Our History
Mission and Values
Medicure Marks Its 25th Anniversary
People and Culture
Careers
AGGRASTAT® (tirofiban HCl) injection
Zypitamag®
Pipeline
Drug Safety
Medical Information
Patient Information
Events
Presentations / Conference Calls
Stock Information
Annual Reports
Quarterly Reports
Corporate Governance
Investor Contacts
Copyright © 2024 Medicure Inc. All Rights Reserved. | Privacy Statement